Article
Is TP53 dysfunction required for BRCA1-associated carcinogenesis?
Molecular and cellular endocrinology - 10 Sept 1999
Schuyer M, Berns E M
Abstract excerpt
The identification of the breast/ovarian susceptibility genes, BRCA1 and BRCA2 was an important advancement in the field of breast and ovarian cancer research. About 40-50% of site specific hereditary breast cancers and up to 80% of hereditary breast-ovarian cancers result from mutations in the BRCA1 gene. Although BRCA1 mediates multiple functions in the cell, including a role in DNA damage repair and gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
